Home / Partnerships


Partnering and collaborations are essential parts of PEPTONIC medical’s business model. We are dependent on our partners for advancing the development of our pipeline products according to our plans and expectations. Hence, we put a lot of emphasis on partnering activities and on managing our partnerships and alliances.


PEPTONIC medical’s most advanced program – Vagitocin® (oxytocin) for the treatment of vaginal atrophy – is in clinical development (Phase 2). We are seeking partners for advancing the program towards registration and commercial launch.

In addition to vaginal atrophy, PEPTONIC medical owns patents relating to a number of medical indications and uses. Please, contact us for more information about these opportunities.


For information about partnering and partnering opportunities, please contact;

Johan Inborr

Chief Executive Officer
+46 708 853 893


Contact us

Please contact us if you would like to know more about PEPTONIC medical or Vagitocin®.

Contacts »

Subscribe for press releases

Would you like to receive press releases and news from PEPTONIC Medical straight to your email? Register for our newsletter service on aktietorget.se.

Subscribe for press releases and news »